» Articles » PMID: 24778349

Measurements of the Neutron Dose Equivalent for Various Radiation Qualities, Treatment Machines and Delivery Techniques in Radiation Therapy

Overview
Journal Phys Med Biol
Publisher IOP Publishing
Date 2014 Apr 30
PMID 24778349
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

In radiation therapy, high energy photon and proton beams cause the production of secondary neutrons. This leads to an unwanted dose contribution, which can be considerable for tissues outside of the target volume regarding the long term health of cancer patients. Due to the high biological effectiveness of neutrons in regards to cancer induction, small neutron doses can be important. This study quantified the neutron doses for different radiation therapy modalities. Most of the reports in the literature used neutron dose measurements free in air or on the surface of phantoms to estimate the amount of neutron dose to the patient. In this study, dose measurements were performed in terms of neutron dose equivalent inside an anthropomorphic phantom. The neutron dose equivalent was determined using track etch detectors as a function of the distance to the isocenter, as well as for radiation sensitive organs. The dose distributions were compared with respect to treatment techniques (3D-conformal, volumetric modulated arc therapy and intensity-modulated radiation therapy for photons; spot scanning and passive scattering for protons), therapy machines (Varian, Elekta and Siemens linear accelerators) and radiation quality (photons and protons). The neutron dose equivalent varied between 0.002 and 3 mSv per treatment gray over all measurements. Only small differences were found when comparing treatment techniques, but substantial differences were observed between the linear accelerator models. The neutron dose equivalent for proton therapy was higher than for photons in general and in particular for double-scattered protons. The overall neutron dose equivalent measured in this study was an order of magnitude lower than the stray dose of a treatment using 6 MV photons, suggesting that the contribution of the secondary neutron dose equivalent to the integral dose of a radiotherapy patient is small.

Citing Articles

Complete patient exposure during paediatric brain cancer treatment for photon and proton therapy techniques including imaging procedures.

De Saint-Hubert M, Boissonnat G, Schneider U, Baumer C, Verbeek N, Esser J Front Oncol. 2023; 13:1222800.

PMID: 37795436 PMC: 10546320. DOI: 10.3389/fonc.2023.1222800.


Effect of simultaneous integrated boost concepts on photoneutron and distant out-of-field doses in VMAT for prostate cancer.

Gauter-Fleckenstein B, Schonig S, Mertens L, Oppitz H, Siebenlist K, Ehmann M Strahlenther Onkol. 2023; 200(3):219-229.

PMID: 37707518 PMC: 10876496. DOI: 10.1007/s00066-023-02138-x.


The application of graphene/h-BN metamaterial in medical linear accelerators for reducing neutron leakage in the treatment room.

Hassanpour M, Hassanpour M, Rezaie M, Khezripour S, Faruque M, Khandaker M Phys Eng Sci Med. 2023; 46(3):1023-1032.

PMID: 37219796 DOI: 10.1007/s13246-023-01269-w.


Validation of a Monte Carlo Framework for Out-of-Field Dose Calculations in Proton Therapy.

De Saint-Hubert M, Verbeek N, Baumer C, Esser J, Wulff J, Nabha R Front Oncol. 2022; 12:882489.

PMID: 35756661 PMC: 9213663. DOI: 10.3389/fonc.2022.882489.


Peripheral Organ Equivalent Dose Estimation Procedure in Proton Therapy.

Domingo C, Lagares J, Romero-Exposito M, Sanchez-Nieto B, Nieto-Camero J, Terron J Front Oncol. 2022; 12:882476.

PMID: 35692801 PMC: 9176390. DOI: 10.3389/fonc.2022.882476.